Taken together, this study points towards a specific role of isoQC and pGlu-CCL2 in cognitive decline in AD and underlines the therapeutic potential of targeting the generation of pGlu-CCL2 by inhibition of isoQC. This evidence concerns the gene CCL2 and Mental deterioration.